Facebook tracking pixel
S10.AI
ICD-10-CM · K81.0GeneralSystemic

Acute Cholecystitis

Understanding Acute Cholecystitis diagnosis, symptoms, and treatment. Find information on Acute Gallbladder Inflammation including clinical documentation, medical coding, ICD-10 codes, and healthcare best practices for managing this condition. Learn about the causes, risk factors, and differential diagnosis of Acute Cholecystitis for improved patient care and accurate medical coding.

Also known as
Acute Gallbladder Inflammation
Definition

Sudden inflammation of the gallbladder, often due to gallstones.

Clinical signs

Right upper abdominal pain, fever, nausea, vomiting, tenderness to touch.

Common settings

Emergency room, hospital admission, surgical consultation.

Related Codes

ICD-10 Code Families

Complete code families applicable to K81.0

K80-K87
Diseases of the gallbladder, biliary tract
K81
Cholecystitis
R10-R19
Symptoms and signs involving the abdomen and pelvis
Code Comparison

When to use each related code

DescriptionWhen to use
Sudden gallbladder inflammation, often with stones.Use for acute right upper quadrant pain, fever, and positive Murphy's sign. Consider cholelithiasis if stones present.
Gallstones without inflammation.Use for biliary colic, episodic pain, or asymptomatic stones found incidentally. Good for preventative care and monitoring.
Chronic gallbladder inflammation.Use for recurrent biliary pain, history of acute cholecystitis, or gallbladder wall thickening on imaging.
Documentation

Best-practice checklist

  • Document Murphy's sign presence/absence.
  • Record ultrasound findings: gallstones, wall thickening.
  • Note patient's pain characteristics: location, severity, radiation.
  • Document fever, nausea, vomiting, and other symptoms.
  • Include WBC count and other relevant lab results.
Coding & Audit Risks

Common pitfalls to avoid

Unspecified Cholecystitis

Coding acute cholecystitis without specifying type (e.g., calculous, acalculous) may lead to claim denials. ICD-10-CM requires greater specificity.

Missing Co-morbidities

Failing to code associated conditions like sepsis or choledocholithiasis with acute cholecystitis impacts DRG assignment and reimbursement.

Clinical Validation Gaps

Insufficient documentation linking the diagnosis of acute cholecystitis to clinical findings can trigger audits and coding queries.

Mitigation

Best-practice tips

  • 01Timely diagnosis using ICD-10 K81.0 for accurate reimbursement.
  • 02Detailed HPI documentation improves CDI & risk adjustment.
  • 03Confirm diagnosis with ultrasound per clinical guidelines for compliance.
  • 04Early surgical consult for cholecystectomy optimizes patient outcomes.
  • 05Monitor labs (WBC, LFTs) and document changes for improved care.
Clinical Decision Support

Step-by-step checklist

  1. 1

    Verify RUQ pain, tenderness

  2. 2

    Check fever, leukocytosis

  3. 3

    Confirm gallbladder wall thickening or pericholecystic fluid on imaging (US/CT)

  4. 4

    Assess Murphy's sign positivity

Documentation Template

Ready-to-paste narrative

Patient presents with acute right upper quadrant pain consistent with acute cholecystitis.  Symptoms onset began [timeframe] and include [list symptoms, e.g., sharp, cramping, or constant pain radiating to the right shoulder, nausea, vomiting, fever, chills].  Patient reports [positive or negative] Murphy's sign.  Differential diagnosis includes biliary colic, choledocholithiasis, pancreatitis, and peptic ulcer disease.  Physical examination reveals [relevant findings, e.g., tenderness in the right upper quadrant, guarding, rebound tenderness].  Laboratory results show [list pertinent lab values, e.g., elevated white blood cell count, elevated alkaline phosphatase, elevated bilirubin].  Abdominal ultrasound findings suggest [describe findings, e.g., gallbladder wall thickening, pericholecystic fluid, gallstones]. Impression is acute cholecystitis.  Plan includes intravenous fluids, pain management with analgesics,  and consultation with general surgery for possible cholecystectomy.  Patient education provided regarding the diagnosis, treatment options, and potential complications of acute cholecystitis including gangrene and perforation.  Patient understands and agrees with the plan.  Follow-up scheduled for [date/time] for reassessment and discussion of surgical intervention.  ICD-10 code K81.0 and CPT codes for evaluation and management, ultrasound, and potential surgical consult were considered for medical billing and coding.
FAQs

Common questions and answers

What are the most reliable diagnostic imaging modalities for differentiating acute cholecystitis from other biliary pathologies like choledocholithiasis or cholangitis in a patient presenting with right upper quadrant pain?+

While physical examination and laboratory findings can suggest acute cholecystitis, imaging is crucial for definitive diagnosis and differentiation from other biliary conditions. Ultrasonography is often the first-line imaging modality due to its wide availability, lack of ionizing radiation, and ability to visualize gallbladder wall thickening, pericholecystic fluid, and gallstones. However, it can be operator-dependent and limited in visualizing the distal common bile duct. Cholescintigraphy (HIDA scan) offers higher specificity for acute cholecystitis by demonstrating cystic duct obstruction, a hallmark of the condition. For complex cases or when suspicion for choledocholithiasis or cholangitis is high, Magnetic Resonance Cholangiopancreatography (MRCP) or Endoscopic Retrograde Cholangiopancreatography (ERCP) can provide detailed visualization of the biliary tree. Consider implementing a diagnostic algorithm that utilizes ultrasonography initially, followed by cholescintigraphy or MRCP/ERCP as needed based on clinical suspicion and ultrasound findings. Explore how different imaging modalities can be combined for a comprehensive evaluation of biliary disease.

How do I manage a patient with suspected early acute cholecystitis who presents with mild symptoms and inconclusive ultrasound findings?+

Managing patients with suspected early acute cholecystitis and equivocal ultrasound findings requires careful clinical judgment. While early cholecystectomy is generally recommended for confirmed acute cholecystitis, observation with serial abdominal examinations and repeat imaging (e.g., a repeat ultrasound within 24-48 hours or a cholescintigraphy) may be appropriate for patients with mild symptoms and uncertain diagnosis. Supportive care, including intravenous fluids, pain management with non-steroidal anti-inflammatory drugs (NSAIDs) or opioids if needed, and nil per os (NPO) status should be initiated. Close monitoring for worsening symptoms such as increasing pain, fever, or leukocytosis is essential. If symptoms persist or worsen despite conservative management, early surgical consultation for laparoscopic cholecystectomy is warranted. Learn more about the Tokyo Guidelines 2018 for the management of acute cholecystitis.

What are the key considerations for antibiotic selection and duration in patients with acute cholecystitis, particularly in the context of rising antimicrobial resistance?+

Antibiotic therapy in acute cholecystitis aims to cover common biliary pathogens, primarily gram-negative enteric bacteria and anaerobes. Empiric therapy typically involves a broad-spectrum antibiotic with activity against these organisms, such as a second or third-generation cephalosporin (e.g., cefuroxime, ceftriaxone), a fluoroquinolone with anaerobic coverage (e.g., moxifloxacin), or a combination of ampicillin-sulbactam. The choice of antibiotic should consider local resistance patterns and patient allergies. Duration of antibiotic therapy is typically 4-7 days, ideally guided by clinical response and culture results if obtained. For patients with severe acute cholecystitis, complicated by gangrene, perforation, or empyema, longer courses of antibiotics and broader coverage may be necessary. Explore how antimicrobial stewardship principles can be applied to optimize antibiotic use in acute cholecystitis and minimize the development of resistance.

Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.

Coding standard: ICD-10-CM, current FY guidelines.